News

Meridianbet Shortlisted for Exclusive License in Brazil

Meridianbet Shortlisted for Exclusive License in Brazil

Meridianbet Shortlisted for a Key License

Golden Matrix Group Inc. (NASDAQ: GMGI), a leading developer of online gaming platforms and systems, is excited to announce that its subsidiary, Meridianbet, has made it onto the shortlist for a coveted sports betting and iGaming license in Brazil. This opportunity arises as Brazil's legal sports betting and iGaming market is expected to be one of the most significant advancements in the industry.

Application Process Overview

The application process was highly competitive, with 113 operators competing for a prioritized license before the deadline. Meridianbet's application, identified by request number 56.195.600/0001-07, has successfully positioned the company among a select group of global operators. The processing of licenses for these priority applicants is anticipated to occur by January 1, 2025, coinciding with the expected launch of Brazil’s gaming market.

The Importance of the Brazilian Market

Meridianbet's inclusion on this exclusive list underscores its potential to become a significant player in the rapidly growing Brazilian gaming landscape. Brazil is projected to evolve into one of the largest gaming markets globally, offering substantial opportunities for both Meridianbet and Golden Matrix Group.

Insights from Leadership

Brian Goodman, CEO of Golden Matrix Group, highlighted the transformative potential of the Brazilian market, stating, "The Brazilian market is set to be a game-changer for all of Golden Matrix Group, but also for the global gaming industry as a whole. This milestone signifies a critical moment in our ongoing global expansion, showcasing our commitment to excellence in delivering premier gaming experiences."

License Scope and Market Forecast

Meridianbet's application covers both sports betting and iGaming (online casino), making it one of the few operators ready to provide a full range of gaming experiences to players in Brazil. The Brazilian gambling sector is projected to achieve an impressive $34 billion in sports betting turnover by 2028, leading to significant gross wins for onshore operations.

Nationwide Reach

This federal-level licensing process differs notably from the state-by-state approach seen in the United States. It grants Meridianbet essential nationwide access, enabling it to reach a diverse and engaged audience across Brazil's expanding marketplace.

About Golden Matrix Group

Golden Matrix Group is a well-established B2B and B2C gaming technology company that serves various international markets. Its B2B division focuses on developing and licensing proprietary gaming platforms, while the B2C division, which includes Meridianbet, manages regulated online sports betting and gaming operations.

About Meridianbet

Founded in 2001, Meridianbet is a recognized name in online sports betting and gaming, holding licenses and operating in 17 jurisdictions across Europe, Africa, and South America. The company employs proprietary technology and scalable systems to maintain a seamless presence across retail, desktop, and mobile platforms.

Frequently Asked Questions

What does it mean for Meridianbet to be shortlisted?

Being shortlisted for an exclusive sports betting and iGaming license in Brazil represents a significant opportunity for Meridianbet and highlights its standing in the global gaming industry.

When is Brazil’s gaming market expected to launch?

The processing of prioritized license applications is expected to be completed by January 1, 2025, which aligns with the anticipated launch of Brazil's legal sports betting and iGaming market.

What does Meridianbet's application entail?

Meridianbet's application includes both sports betting and iGaming, positioning the company to offer a wide variety of gaming options to Brazilian players.

Why is the Brazilian market significant?

Brazil is projected to become one of the largest gaming markets in the world, with substantial revenue forecasts for sports betting, presenting a lucrative opportunity for growth and expansion.

How does Golden Matrix Group function?

Golden Matrix Group operates a B2B division focused on gaming platform development and licensing, along with a B2C division that oversees regulated online sports betting and gaming operations, including Meridianbet.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading